CBT Stock Recent News

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

CBT's upside is fueled by strong segment performance, consistent earnings beats and an upbeat fiscal 2024 outlook.

NetApp, Cabot, Leidos Holdings, Charles River and HCA Healthcare could be compelling picks amid a low rate scenario.

The new manufacturing operation of CBT will boost the domestic supply chain for crucial battery ingredients, lowering dependency on foreign imports.

BOSTON--(BUSINESS WIRE)--Cabot Corporation (NYSE: CBT), a global specialty chemicals and performance materials company, announced it has been selected for an award negotiation of up to $50 million by the U.S. Department of Energy's (DOE) Office of Manufacturing and Energy Supply Chains. This grant, part of the Bipartisan Infrastructure Law, will support Cabot's development of a new U.S.-based manufacturing facility to produce battery-grade carbon nanotubes (CNTs) and conductive additive dispers.

CBT's shares hit a 52-week high, fueled by strong segment growth, higher earnings and an upbeat outlook on robust market demand.

Cabot (CBT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Here is how Cabot (CBT) and Vista Gold (VGZ) have performed compared to their sector so far this year.

Cabot (CBT) possesses solid growth attributes, which could help it handily outperform the market.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.